In this paper, we describe how data collection has evolved across the COGA project (Part 1), as well as key areas of investigation and findings that have emerged from the COGA project (Part 2), in the hope of inspiring additional scientists to collaborate and work with this rich dataset. The increasing availability of the DNA sequence of the entire human genome and knowledge of variations in that sequence among people are greatly aiding the current phase of the research. Particularly important to the current work is the use of the sequence data to identify which genes are located within the regions that have shown linkage with alcoholism and the other phenotypes examined in the COGA analyses and to identify variations (i.e., polymorphisms) within those genes. Where the available data are incomplete or insufficient, COGA researchers are seeking these polymorphisms themselves. Of particular value are single-nucleotide polymorphisms (SNPs)—sites at which people differ in a single base pair—in or near genes within the regions of interest. COGA investigators are doing additional genotyping of SNPs in and near candidate genes in the regions of linkage for further analysis of linkage and linkage disequilibrium (i.e., the nonrandom association of alleles).
A biochemical technique called polymerase chain reaction (PCR) can help identify a person’s alleles for each marker site. Using small amounts of the person’s DNA, scientists can establish the length of each marker allele, which depends on the number of repeats present at that site. By comparing this genetic information with phenotypic information (e.g., whether a person is alcoholic), researchers can determine whether any region of the genome (i.e., any marker) is inherited in a manner consistent with its containing a gene affecting the risk for alcoholism. During the past few years, and largely as a result of the Human Genome Project, researchers have identified thousands of markers called microsatellites and mapped their locations on the human genome.
Molecular Biology Databases
- One example is a mutation seen in about 40% of Asians inthe gene producing the enzyme aldehyde dehydrogenase (ALDH) that isresponsible for the metabolism of the first breakdown product of alcohol,acetaldehyde.
- By considering AD and abuse under single umbrella increased the number of diagnosed subjects, but this number was still not large enough to design powerful GWAS studies.
- Studies have shown that individuals with a genetic predisposition to alcoholism have abnormalities in their dopamine system, which may contribute to their increased risk of developing an addiction.
- Another approach that is essential for optimal understanding of gene effectsis referred to as functional genetic studies.
It is hoped that this brief review has helped alcohol and drug researcherswho work outside the genetics field to gain a useful understanding of the currentdevelopments and exciting future work likely to accrue in our field. Epigenetic studies of AUD have emerged as an important avenue for understanding the complex interplay among genetics, environment, and gene regulation in the development and progression of AUD. Epigenetic https://ecosoberhouse.com/ factors include transcription factors, noncoding RNAs, DNA modifications, or histone modifications that alter the gene expression and consequently affect phenotypes, without changing the DNA sequence (121, 122). While epigenetic status is highly heritable and affected by environmental factors, including alcohol exposures, certain epigenetic changes in specific brain regions have been implicated in the etiology of AUD (123). The search for genes that modify a person’s susceptibility to alcohol abuse and dependence is a central concern of alcohol studies. With the powerful and reliable assessment tools now available, COGA ultimately will identify one or more such genes.
Are there specific genes that are associated with alcoholism?
Sanchez-Roige and Palmer noted that their group has developed a 10-year partnership with 23andMe that has focused on numerous traits, especially those with relevance for addiction. Published today in Nature Mental Health, the study was led by researchers at the Washington University in St. Louis, along with more than 150 coauthors from around the world. It was supported by the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Mental Health (NIMH), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute on Aging.
ALCOHOL CHALLENGE COMPONENT
Thesubsequent development of more powerful statistical methods along with increasinginterest in genetic questions contributed to a more sophisticated understanding of genesand chromosomes and the isolation of DNA by the early 1940s (Avery et al., 1944). This overview examined certain popular tools and how they can be used to further the understanding of alcoholism. Though epidemiologists have various methods for examining gene–environment how do genetics affect a persons likelihood for becoming an alcoholic interaction, the relative number of studies focusing on applying and evaluating these tools are few. At the heart of the MDR approach is a feature or attribute construction algorithm that creates a new attribute (characteristic) by pooling genotypes from multiple SNPs.
Epigenetics, the study of changes in gene expression without changes to the underlying DNA sequence, also holds promise for future alcoholism research. Understanding how environmental factors can influence gene expression and contribute to the development of alcoholism can provide valuable insights into prevention strategies. In conclusion, individuals with a genetic predisposition to alcoholism require supportive networks to assist them in navigating the challenges of their condition. These networks should provide educational resources, community support groups, and access to professional guidance and counseling.
Similar to the waves of technologies in genomic studies, microarrays and next-generation sequencing techniques have been applied to epigenetic studies of AUD (Table 3). (a) Different definitions of AUD and proxy phenotypes (e.g., AUDIT-P) have shared genetic architecture, resulting in improved power in gene discovery when they are combined from different cohorts (78, 80). Deep phenotyping (either using same definition or focusing on subphenotypes) in larger cohorts could reduce the phenotypic heterogeneity and increase the possibility of identifying trait-specific associations and pathways (92). As shown in Table 7, by the time data collection had ended in 2019, the paths of the participants from case families continued to diverge from those of their counterparts from comparison families in numerous domains. This was observed in the substance use realm, where across all types of substances, use began at much younger ages, and prevalence estimates for disorders were 1.4 to over 4 times higher among those in case compared with comparison families. Excess prevalence in participants in case compared with comparison families was also observed for major depression, conduct disorder, and ASPD.
Nature vs. Nurture: Is Alcohol Use Disorder in Our Genes?
The genes with the clearest contribution to the risk for alcoholism andalcohol consumption are alcohol dehydrogenase 1B (ADH1B) andaldehyde dehydrogenase 2 (ALDH2; mitochondrial aldehydedehydrogenase), two genes central to the metabolism of alcohol (Figure 1)20. Alcohol is metabolized primarily in the liver, although thereis some metabolism in the upper GI tract and stomach. The first step in ethanolmetabolism is oxidation to acetaldehyde, catalyzed primarily by ADHs; there are 7closely related ADHs clustered Sobriety on chromosome 4 (reviewed in20). The second step is metabolism of theacetaldehyde to acetate by ALDHs; again, there are many aldehyde dehydrogenases,among which ALDH2 has the largest impact on alcohol consumption20.
PART 1: OVERVIEW OF DATA COLLECTION
Some of these genes have been identified, including twogenes of alcohol metabolism, ADH1B and ALDH2,that have the strongest known affects on risk for alcoholism. Studies arerevealing other genes in which variants impact risk for alcoholism or relatedtraits, including GABRA2, CHRM2,KCNJ6, and AUTS2. As larger samples areassembled and more variants analyzed, a much fuller picture of the many genesand pathways that impact risk will be discovered. This approachidentifies regions of chromosomes that may contain genetic variations affectingthe risk for the trait and that are potentially fruitful areas to evaluate forspecific genes. Association studies work to identify markers (or genes) that aremore (or less) common in people with a trait than in those without. Thesestudies sometimes begin by searching for genes that might be related to thetrait (e.g., AUDs) by looking at genes that lie in chromosomal regions ofinterest highlighted in linkage analyses.
Scientists from Europe, Asia, South America, and Oceania also are using parts or all of the COGA assessment protocol in related studies of the genetics of alcoholism. This collaborative effort will result in a large data set that will permit the study of alcoholism phenotypes across a variety of ethnic and cultural populations. To determine SSAGA’s reliability, researchers conducted test-retest studies both within and between different COGA centers. The studies indicated good-to-high reliability for DSM–III–R-based diagnoses of substance-use disorders (e.g., alcoholism), depression, and antisocial personality disorder (Bucholz et al. 1994, 1995). This is relatively small in comparison to schizophrenia, where genetics can explain eighty percent of the disease predisposition. Therefore, as research progresses, consideration must still be made for the environment—the “nurture”—that individuals were raised and live in.